We are live on ! Find out more
ONC

BeOne Medicines Ltd
ONC

220 hedge funds and large institutions have $9.45B invested in BeOne Medicines Ltd in 2020 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 98 increasing their positions, 64 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more call options, than puts

Call options by funds: $13.2M | Put options by funds: $8.42M

56% more capital invested

Capital invested by funds: $6.06B → $9.45B (+$3.39B)

53% more repeat investments, than reductions

Existing positions increased: 98 | Existing positions reduced: 64

26% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 23

2% more funds holding

Funds holding: 215 → 220 (+5)

0.08% more ownership

Funds ownership: 4.92% → 5% (+0.08%)

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

Holders
220
Holders Change
+5
Holders Change %
+2.33%
% of All Funds
4.51%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
29
Increased
98
Reduced
64
Closed
23
Calls
$13.2M
Puts
$8.42M
Net Calls
+$4.75M
Net Calls Change
-$744K

Top Buyers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
+$40.2M
2
Invesco
Invesco
Georgia
+$34.5M
3
Temasek Holdings
Temasek Holdings
Singapore
+$32.9M
4
AG
Artal Group
Luxembourg
+$32.6M
5
BlackRock
BlackRock
New York
+$30.9M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$44.4M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$19.7M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$14M
4
State Street
State Street
Massachusetts
-$11.3M
5
Victory Capital Management
Victory Capital Management
Texas
-$10.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Manulife (Manufacturers Life Insurance)
76
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3.84M +$879K +5,400 +36%
AAMU
77
Amundi Asset Management US
Massachusetts
$3.69M -$126K -775 -4%
Public Sector Pension Investment Board (PSP Investments)
78
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$3.63M -$32.6K -200 -1%
Royal Bank of Canada
79
Royal Bank of Canada
Ontario, Canada
$3.57M +$7.98K +49 +0.3%
Canada Life
80
Canada Life
Manitoba, Canada
$3.51M -$195K -1,200 -6%
State of Wisconsin Investment Board
81
State of Wisconsin Investment Board
Wisconsin
$3.48M -$1.4M -8,591 -32%
Citigroup
82
Citigroup
New York
$3.48M +$23.6K +145 +0.8%
Canada Pension Plan Investment Board
83
Canada Pension Plan Investment Board
Ontario, Canada
$3.39M +$1.87M +11,459 +175%
Aviva
84
Aviva
United Kingdom
$3.21M +$26.5K +163 +1%
Charles Schwab
85
Charles Schwab
California
$3.18M +$30.1K +185 +1%
AG
86
Aperio Group
California
$3.14M +$222K +1,361 +9%
GC
87
Guggenheim Capital
Illinois
$3.1M +$399K +2,453 +18%
PAM
88
Panagora Asset Management
Massachusetts
$2.84M +$362K +2,225 +17%
Bank of Montreal
89
Bank of Montreal
Ontario, Canada
$2.82M +$488K +2,998 +27%
Aberdeen Group
90
Aberdeen Group
United Kingdom
$2.5M +$29.3K +180 +1%
DekaBank Deutsche Girozentrale
91
DekaBank Deutsche Girozentrale
Germany
$2.35M -$962K -5,908 -32%
OAM
92
Oppenheimer Asset Management
New York
$2.35M +$19.9K +122 +1%
Public Employees Retirement Association of Colorado
93
Public Employees Retirement Association of Colorado
Colorado
$2.31M – – –
Victory Capital Management
94
Victory Capital Management
Texas
$2.29M -$10.9M -67,156 -85%
Handelsbanken Fonder
95
Handelsbanken Fonder
Sweden
$2.26M +$1.95M +12,000 New
BNP Paribas Financial Markets
96
BNP Paribas Financial Markets
France
$2.2M -$2.67M -16,429 -58%
Zurich Cantonal Bank
97
Zurich Cantonal Bank
Switzerland
$2.15M -$13.3K -82 -0.7%
NSRI
98
New Silk Road Investment
Singapore
$2.12M -$2.03M -12,450 -53%
BNP Paribas Asset Management
99
BNP Paribas Asset Management
France
$2.05M +$33.9K +208 +2%
VIA
100
Vident Investment Advisory
Georgia
$2.03M -$157K -962 -8%
2 3
4
5 6

ONC Hedge Fund Activity: Q2 2020 in Review

220 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q2 2020, worth a combined $9.45B — up 56% from $6.06B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new ONC positions and 23 closed out — a net gain of 6 holders — while 98 added to existing stakes and 64 trimmed.

The largest buyer was Capital International Investors, adding an estimated $40.2M. The largest seller was Fidelity Investments, cutting an estimated $44.4M.

  • 220 institutional investors held BeOne Medicines Ltd (ONC) as of Q2 2020, up from 215 in Q1 2020.
  • Funds reported $9.45B of BeOne Medicines Ltd stock for Q2 2020, up 56% quarter-over-quarter.
  • 29 funds opened new BeOne Medicines Ltd positions in Q2 2020 and 23 closed out, a net change of +6 holders.
  • The largest BeOne Medicines Ltd buyer in Q2 2020 was Capital International Investors, an estimated $40.2M added.
  • The largest BeOne Medicines Ltd seller in Q2 2020 was Fidelity Investments, an estimated $44.4M sold.

Based on aggregated 13F filings for Q2 2020.